The Long Road to Riches in the Life Sciences

The highest paying jobs in life sciences involve clinical research, bioinformatics, or bioengineering, according to an earnings survey by The Scientist and Abbott, Langer & Associates Inc. The median salaries plus cash compensation for jobs in these disciplines, from $75,000 to $77,000, are 36-40 percent higher than the $55,000 median pay for the 7,902 life scientists who provided usable responses. Salaries for doctorate bioinformaticians who also hold medical degrees prove to be even higher

Written byPaula Park
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The salaries in these specialized fields suggest that life science researchers can boost their pay by acquiring clinical, engineering, and computer skills. These earning trends also reflect a theme supported by other survey data: Supply and demand rule the labor market. The need for bioinformaticians, bioengineers, and clinical researchers outpaces the supply.

"There's been some concern in the country for the last 25 years about the diminishing number of clinical researchers, so the going rate has gone up," says Elvin Smith, associate vice president for Health Sciences, Texas A&M University. "Bioinformatics is a relatively new field; there is a gap between the demand for talent and the available talent."

The salary survey statistics on clinical research, bioengineering, and bioinformatics are reflected in the Abbott, Langer & Associates report "Compensation of Life Scientists." For the survey, The Scientist E-mailed invitations to 23,933 subscribers of the print edition of The Scientist, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies